Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
Completed · Not applicable
Conditions studied: Neonatal Hypoglycemia
In brief
Hypoglycemia is the most common metabolic problem faced after birth. The investigators will be studying the utility of using a continuous glucose monitoring(CGM) system to more closely monitor low blood sugars in newborns. The investigators will evaluate the number of hypoglycemic events detected using CGM and compare it to those detected using current standard of care screening methods.
Key facts
- Study ID
- NCT03032523
- Run by
- Stanford University
- People needed
- 21
- Starts
- 2016-10-01
- Expected to finish
- 2018-04-01
- Last updated by the study team
- 2019-07-29
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Infants who are at least 34 weeks gestation that are born to mothers with gestational or pre-gestational diabetes and are admitted to LPCH are eligible for the study.
You may not qualify if…
- Infants <2,000 grams will be excluded from the study. Infants will also be excluded if they have an anomaly of the skin or subcutaneous tissue that would prevent proper adhesion, placement, and function of the sensor.
Where it is running
- Stanford University — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.